# Biotech Daily Digest — 2025-11-07

**48 items from 5 sources**

## Summary by Source

- Eli Lilly Press Releases: 2 items
- Endpoints News: 12 items
- Fierce Biotech: 4 items
- Regeneron Press Releases: 1 item
- arXiv q-bio: 29 items


## Eli Lilly Press Releases

- **[Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth](https://investor.lilly.com/news-releases/news-release-details/lilly-announces-two-new-executive-committee-members-and)**  
  _Thu, 06 Nov 2025 16:05:00 -0500_  
  INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of two new Executive Committee members and the expansion of other senior leaders' roles designed to accelerate one of the industry's most ambitious pipelines, generate new portfolio

- **[Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans](https://investor.lilly.com/news-releases/news-release-details/lilly-and-us-government-agree-expand-access-obesity-medicines)**  
  _Thu, 06 Nov 2025 13:54:00 -0500_  
  Medicare beneficiaries with obesity or overweight will have access to   Zepbound and orforglipron, if approved, at $50 a month  INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement with the U.S. government to expand access to its obesity


## Endpoints News

- **[ObesityWeek rode the waves of the field's most dramatic week in months](https://endpoints.news/obesityweek-rode-the-waves-of-the-fields-most-dramatic-week-in-months/)**  
  _Fri, 07 Nov 2025 14:30:19 +0000_  
  ATLANTA — At one of the main annual gatherings of researchers and drug developers in the obesity field, Novo Nordisk and Eli Lilly were the talk of the town.

 But it wasn't just because of their ...

- **[Lilly hires Denali executive to run neuroscience division](https://endpoints.news/lilly-hires-denali-executive-to-run-neuroscience-division/)**  
  _Fri, 07 Nov 2025 14:02:21 +0000_  
  Eli Lilly is shaking up its neuroscience and immunology leadership, while giving two longtime executives additional responsibilities.

 The Indiana-based company said Thursday it has hired Carole Ho to be the president ...

- **[#AASLD25: Rivus’ MASH drug cuts liver fat, preserves muscle in mid-stage trial](https://endpoints.news/aasld25-rivus-mash-drug-cuts-liver-fat-preserves-muscle-in-mid-stage-trial/)**  
  _Fri, 07 Nov 2025 13:00:37 +0000_  
  Rivus Pharmaceuticals’ MASH candidate reduced liver fat levels by up to 31.2% at six months in a Phase 2 trial in 221 overweight and obese MASH patients.

 Dosed at 150 mg, 300 mg and 450 ...

- **[Novo Nordisk, Pfizer make personnel waves as they squabble over Metsera](https://endpoints.news/novo-nordisk-pfizer-make-personnel-waves-as-they-squabble-over-metsera/)**  
  _Fri, 07 Nov 2025 12:00:59 +0000_  
  → Are you tired of Novo Nordisk and Pfizer, or are you thirsty for more? They’ve even infiltrated the top of Peer Review as the bickering gets louder and the

- **[Patient in Intellia CRISPR trial dies after being hospitalized with liver injury](https://endpoints.news/patient-in-intellia-crispr-trial-dies-after-being-hospitalized-with-liver-injury/)**  
  _Fri, 07 Nov 2025 02:34:55 +0000_  
  A man in his early 80s who was recently hospitalized with liver injury, a few weeks after receiving an experimental gene editing therapy, died on Wednesday ...

- **[Evommune CEO talks about sticking with $150M IPO plan during government shutdown](https://endpoints.news/evommune-ceo-talks-about-sticking-with-150m-ipo-plan-during-government-shutdown/)**  
  _Fri, 07 Nov 2025 00:28:59 +0000_  
  More biotech IPOs have occurred during the government shutdown than during a seven-month industry dry spell from February to September.

 On Thursday, inflammatory disease biotech Evommune raised $150 million in its initial public offering. Its ...

- **[#ASN25: Eledon plots path forward for kidney transplant drug despite Phase 2 miss](https://endpoints.news/asn25-eledon-plots-path-forward-for-kidney-transplant-drug-despite-phase-2-miss/)**  
  _Thu, 06 Nov 2025 23:30:09 +0000_  
  Eledon Pharmaceuticals on Thursday shared mid-stage data for its drug candidate designed to prevent organ rejection in people who have had a kidney transplant.

 Although tegoprubart technically missed the primary endpoint in the Phase 2 ...

- **[Eisai plots label expansion for subcutaneous Leqembi, details early launch progress](https://endpoints.news/eisai-plots-label-expansion-for-subcutaneous-leqembi-details-early-launch-progress/)**  
  _Thu, 06 Nov 2025 20:26:42 +0000_  
  Eisai said it’s planning a rolling FDA submission next month to expand the use of its Biogen-partnered subcutaneous Alzheimer’s treatment, the latest effort to stoke the companies’ rivalry with Eli Lilly.

 Leqembi was first approved ...

- **[FDA unveils second batch of commissioner voucher winners](https://endpoints.news/fda-unveils-second-batch-of-commissioner-voucher-winners/)**  
  _Thu, 06 Nov 2025 20:07:01 +0000_  
  Eli Lilly’s oral obesity pill orforglipron was among the next six drugs to win the FDA's National Priority Voucher, offering the GLP-1 drug candidate a path to potential approval in as little as one month ...

- **[Novo Nordisk raises Metsera bid again, hoping to top Pfizer's latest offer](https://endpoints.news/novo-raises-bid-again-to-top-pfizers-latest-offer-for-metsera/)**  
  _Thu, 06 Nov 2025 15:56:47 +0000_  
  Novo Nordisk has once again upped its bid for Metsera, according to sources familiar with the matter, in an effort to beat out a raised Pfizer offer that was delivered late Wednesday.

 The exact details ...

- **[Dyne changes plans for DM1 drug again; Dynavax licenses Vaxart's Covid vaccine](https://endpoints.news/dyne-changes-plans-for-dm1-drug-again-dynavax-licenses-vaxarts-covid-vaccine/)**  
  _Thu, 06 Nov 2025 15:43:37 +0000_  
  Plus, news about Cullinan, 4DMT, Axsome, AstraZeneca, Noema, UroGen Pharma, Halozyme and Benitec:

 ↩️ Dyne delays myotonic dystrophy plans again: Dyne said it now expects to submit an application for FDA approval of its ...

- **[#ASN25: Vera outlines full Phase 3 win for kidney drug, preps for FDA filing by year's end](https://endpoints.news/asn25-vera-outlines-full-phase-3-win-for-kidney-drug-preps-for-fda-filing-by-years-end/)**  
  _Thu, 06 Nov 2025 15:11:58 +0000_  
  Vera Therapeutics built its case for a rare kidney disease drug Thursday morning, revealing a fuller Phase 3 dataset after toplining the results earlier this year.

 If the company can convince the FDA — Vera plans ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/patient-dies-after-receiving-intellias-crispr-therapy" hreflang="en">Patient dies after receiving Intellia's CRISPR therapy</a>](https://www.fiercebiotech.com/biotech/patient-dies-after-receiving-intellias-crispr-therapy)**  
  _Nov 7, 2025 4:57am_  
  The patient who was hospitalized after receiving Intellia Therapeutics’ CRISPR therapy nex-z has died. Both phase 3 studies of the candidate remain on hold as the biotech works to understand liver-related events seen in the trials and to develop a risk-mitigation plan.

- **[<a href="https://www.fiercebiotech.com/biotech/axsome-adds-astrazeneca-epilepsy-candidate-pipeline-through-avenue-subsidiary-acquisition" hreflang="en">Axsome adds AstraZeneca epilepsy candidate to pipeline through Avenue subsidiary acquisition</a>](https://www.fiercebiotech.com/biotech/axsome-adds-astrazeneca-epilepsy-candidate-pipeline-through-avenue-subsidiary-acquisition)**  
  _Nov 6, 2025 10:51am_  
  Axsome Therapeutics has wrapped its hands around an epilepsy candidate from AstraZeneca through an acquisition of Avenue Therapeutics' subsidiary Baergic Bio, in a deal potentially worth more than $83 million.

- **[<a href="https://www.fiercebiotech.com/biotech/urogen-hands-anti-ctla4-back-agenus-after-being-unimpressed-phase-1-data" hreflang="en">UroGen hands anti-CTLA-4 drug back to Agenus after being unimpressed with phase 1 data</a>](https://www.fiercebiotech.com/biotech/urogen-hands-anti-ctla4-back-agenus-after-being-unimpressed-phase-1-data)**  
  _Nov 6, 2025 9:12am_  
  UroGen is handing an anti-CTLA-4 antibody back to Agenus after concluding that phase 1 data for the bladder cancer drug didn’t reach the benchmark for further development.

- **[<a href="https://www.fiercebiotech.com/medtech/illumina-shares-rise-china-set-lift-sequencer-export-ban" hreflang="en">Illumina shares rise as China set to lift sequencer export ban</a>](https://www.fiercebiotech.com/medtech/illumina-shares-rise-china-set-lift-sequencer-export-ban)**  
  _Nov 6, 2025 3:31am_  
  China is set to ease restrictions on some Illumina products, giving the sequencing giant a partial reprieve.


## Regeneron Press Releases

- **[Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review](https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-pivotal-trial-met-all-primary-and-secondary)**  
  _Fri, 07 Nov 2025 08:00:00 -0500_  
  Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion and nasal polyps in patients aged 6 years and older compared to placebo Dupixent sBLA accepted for priority review by the U.S.


## arXiv q-bio

- **[Attention-based ROI Discovery in 3D Tissue Images](https://arxiv.org/abs/2511.03751)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03751v1 Announce Type: new 
Abstract: High-dimensional tissue imaging generates highly complex 3D data containing multiple biomarkers, making it challenging to identify biologically relevant regions without an expert user specifying manual labels for regions of interest. We introduce an approach to automati…

- **[Mathematical and Computational Nuclear Oncology: Toward Optimized Radiopharmaceutical Therapy via Digital Twins](https://arxiv.org/abs/2511.03755)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03755v1 Announce Type: new 
Abstract: This article presents the general framework of theranostic digital twins (TDTs) in computational nuclear medicine, designed to support clinical decision-making and improve cancer patient prognosis through personalized radiopharmaceutical therapies (RPTs). It outlines po…

- **[Phenotype discovery of traumatic brain injury segmentations from heterogeneous multi-site data](https://arxiv.org/abs/2511.03767)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03767v1 Announce Type: new 
Abstract: Traumatic brain injury (TBI) is intrinsically heterogeneous, and typical clinical outcome measures like the Glasgow Coma Scale complicate this diversity. The large variability in severity and patient outcomes render it difficult to link structural damage to functional d…

- **[Current validation practice undermines surgical AI development](https://arxiv.org/abs/2511.03769)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03769v1 Announce Type: new 
Abstract: Surgical data science (SDS) is rapidly advancing, yet clinical adoption of artificial intelligence (AI) in surgery remains severely limited, with inadequate validation emerging as a key obstacle. In fact, existing validation practices often neglect the temporal and hier…

- **[Climbing the label tree: Hierarchy-preserving contrastive learning for medical imaging](https://arxiv.org/abs/2511.03771)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03771v1 Announce Type: new 
Abstract: Medical image labels are often organized by taxonomies (e.g., organ - tissue - subtype), yet standard self-supervised learning (SSL) ignores this structure. We present a hierarchy-preserving contrastive framework that makes the label tree a first-class training signal a…

- **[Diffusion Dynamics in Biofilms with Time-Varying Channels](https://arxiv.org/abs/2511.03856)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03856v1 Announce Type: new 
Abstract: A biofilm is a self-contained community of bacteria that uses signaling molecules called autoinducers (AIs) to coordinate responses through the process of quorum sensing. Biofilms exhibit a dual role that drives interest in both combating antimicrobial resistance (AMR)…

- **[CAR T Cells from Code to Clinic: Framing Modeling Approaches with Current Translational Research Goals](https://arxiv.org/abs/2511.03873)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03873v1 Announce Type: new 
Abstract: Chimeric Antigen Receptor (CAR) T cell therapy has transformed immunotherapy for resistant cancers, yet it faces major limitations such as lack of persistence, toxicity, exhaustion, and antigen-negative relapse. Enhancing CAR T cells with genetic circuitry and synthetic…

- **[Simulating the impact of perception bias on social contact surveys for infectious disease modelling](https://arxiv.org/abs/2511.03897)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03897v1 Announce Type: new 
Abstract: Social contact patterns are a key input to many infectious disease models. Contact surveys, where participants are asked to provide information on their recent close and casual contacts with others, are one of the standard methods to measure contact patterns in a popula…

- **[Habitat fragmentation promotes spatial scale separation under resource competition](https://arxiv.org/abs/2511.04097)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04097v1 Announce Type: new 
Abstract: Habitat fragmentation, often driven by human activities, alters ecological landscapes by disrupting connectivity and reshaping species interactions. In such fragmented environments, habitats can be modeled as networks, where individuals disperse across interconnected pa…

- **[Infrared Microscopy of Biochemistry and Metabolism in Single Living Eukaryotic Cells](https://arxiv.org/abs/2511.04143)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04143v1 Announce Type: new 
Abstract: The turn of the millennium has seen a growing interest in the study of live cells by infrared (IR) spectroscopy, driven by the versatility, wealth of molecular information, and potential for high-throughput screening of the technique. Measurements on individual cells, e…

- **[Vector Traits Shape Disease Persistence: A Predator Prey Approach to Dengue](https://arxiv.org/abs/2511.04276)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04276v1 Announce Type: new 
Abstract: Dengue continues to pose a major global threat, infecting nearly 390 million people annually. Recognizing the pivotal role of vector competence (vc), recent research focuses on mosquito parameters to inform transmission modeling and vector control strategies.This study…

- **[Feasibility and Single Parameter Scaling of Extinctions in Multispecies Lotka-Volterra Ecosystems](https://arxiv.org/abs/2511.04327)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04327v1 Announce Type: new 
Abstract: Multispecies ecosystems modelled by generalized Lotka-Volterra equations exhibit stationary population abundances, where large number of species often coexist. Understanding the precise conditions under which this is at all feasible and what triggers species extinctions…

- **[The selective advantage of neighborhood-aware mutants in Moran process](https://arxiv.org/abs/2511.04417)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04417v1 Announce Type: new 
Abstract: Evolution occurs in populations of reproducing individuals. In stochastic descriptions of evolutionary dynamics, such as the Moran process, individuals are chosen randomly for birth and for death. If the same type is chosen for both steps, then the reproductive event is…

- **[The brain as a blueprint: a survey of brain-inspired approaches to learning in artificial intelligence](https://arxiv.org/abs/2511.04455)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04455v1 Announce Type: new 
Abstract: Inspired by key neuroscience principles, deep learning has driven exponential breakthroughs in developing functional models of perception and other cognitive processes. A key to this success has been the implementation of crucial features found in biological neural netw…

- **[Unified Generative Latent Representation for Functional Brain Graphs](https://arxiv.org/abs/2511.04539)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04539v1 Announce Type: new 
Abstract: Functional brain graphs are often characterized with separate graph-theoretic or spectral descriptors, overlooking how these properties covary and partially overlap across brains and conditions. We anticipate that dense, weighted functional connectivity graphs occupy a…

- **[Reproduction Numbers R_0, R_t for COVID-19 Infections with Gaussian Distribution of Generation Times, and of Serial Intervals including Presymptomatic Transmission](https://arxiv.org/abs/2511.04574)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04574v1 Announce Type: new 
Abstract: Basic and instantaneous reproduction numbers, "R" _"0" and "R" _"t" , are important metrics to assess progress of an epidemic and effectiveness of preventative interventions undertaken, and also to estimate coverage needed for vaccination. Reproduction numbers are relat…

- **[Advancing Risk Gene Discovery Across the Allele Frequency Spectrum](https://arxiv.org/abs/2511.04637)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04637v1 Announce Type: new 
Abstract: The discovery of genetic risk factors has transformed human genetics, yet the pace of new gene identification has slowed despite the exponential expansion of sequencing and biobank resources. Current approaches are optimized for the extremes of the allele frequency spec…

- **[SILVI: Simple Interface for Labeling Video Interactions](https://arxiv.org/abs/2511.03819)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03819v1 Announce Type: cross 
Abstract: Computer vision methods are increasingly used for the automated analysis of large volumes of video data collected through camera traps, drones, or direct observations of animals in the wild. While recent advances have focused primarily on detecting individual actions,…

- **[Which Similarity-Sensitive Entropy?](https://arxiv.org/abs/2511.03849)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03849v1 Announce Type: cross 
Abstract: A canonical step in quantifying a system is to measure its entropy. Shannon entropy and other traditional entropy measures capture only the information encoded in the frequencies of a system's elements. Recently, Leinster, Cobbold, and Reeve (LCR) introduced a method…

- **[Use of Continuous Glucose Monitoring with Machine Learning to Identify Metabolic Subphenotypes and Inform Precision Lifestyle Changes](https://arxiv.org/abs/2511.03986)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03986v1 Announce Type: cross 
Abstract: The classification of diabetes and prediabetes by static glucose thresholds obscures the pathophysiological dysglycemia heterogeneity, primarily driven by insulin resistance (IR), beta-cell dysfunction, and incretin deficiency. This review demonstrates that continuous…

- **[Simple 3D Pose Features Support Human and Machine Social Scene Understanding](https://arxiv.org/abs/2511.03988)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.03988v1 Announce Type: cross 
Abstract: Humans can quickly and effortlessly extract a variety of information about others' social interactions from visual input, ranging from visuospatial cues like whether two people are facing each other to higher-level information. Yet, the computations supporting these a…

- **[Fitting Reinforcement Learning Model to Behavioral Data under Bandits](https://arxiv.org/abs/2511.04454)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04454v1 Announce Type: cross 
Abstract: We consider the problem of fitting a reinforcement learning (RL) model to some given behavioral data under a multi-armed bandit environment. These models have received much attention in recent years for characterizing human and animal decision making behavior. We prov…

- **[Neural Computation Without Slots: Steps Towards Biologically Plausible Memory and Attention in Natural and Artificial Intelligence](https://arxiv.org/abs/2511.04593)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.04593v1 Announce Type: cross 
Abstract: Many models used in artificial intelligence and cognitive science rely on multi-element patterns stored in "slots" - dedicated storage locations - in a digital computer. As biological brains likely lack slots, we consider how they might achieve similar functional outc…

- **[Integrating protein sequence embeddings with structure via graph-based deep learning for single-residue property prediction](https://arxiv.org/abs/2502.17294)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2502.17294v2 Announce Type: replace 
Abstract: Understanding the intertwined contributions of amino acid sequence and spatial structure is essential to explain protein behaviour. Here, we introduce INFUSSE (Integrated Network Framework Unifying Structure and Sequence Embeddings), a deep learning framework for th…

- **[Convergence-divergence models: Generalizations of phylogenetic trees modeling gene flow over time](https://arxiv.org/abs/2504.07384)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2504.07384v2 Announce Type: replace 
Abstract: Phylogenetic trees are simple models of evolutionary processes. They describe conditionally independent divergent evolution from common ancestors. However, they often lack the flexibility to represent processes like introgressive hybridization, which leads to gene f…

- **[Modeling and Inferring Metacommunity Dynamics with Maximum Caliber](https://arxiv.org/abs/2506.17495)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2506.17495v2 Announce Type: replace 
Abstract: A major challenge for community ecology is using spatio-temporal data to infer parameters of dynamical models without conducting laborious experiments. We present a novel framework from statistical physics -- Maximum Caliber -- to characterize the temporal dynamics…

- **[LA-MARRVEL: A Knowledge-Grounded and Language-Aware LLM Reranker for AI-MARRVEL in Rare Disease Diagnosis](https://arxiv.org/abs/2511.02263)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2511.02263v3 Announce Type: replace 
Abstract: Diagnosing rare diseases requires linking gene findings with often unstructured reference text. Current pipelines collect many candidate genes, but clinicians still spend a lot of time filtering false positives and combining evidence from papers and databases. A key…

- **[Scaling Laws for Task-Optimized Models of the Primate Visual Ventral Stream](https://arxiv.org/abs/2411.05712)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2411.05712v3 Announce Type: replace-cross 
Abstract: When trained on large-scale object classification datasets, certain artificial neural network models begin to approximate core object recognition behaviors and neural response patterns in the primate brain. While recent machine learning advances suggest that s…

- **[scMEDAL for the interpretable analysis of single-cell transcriptomics data with batch effect visualization using a deep mixed effects autoencoder](https://arxiv.org/abs/2411.06635)**  
  _Fri, 07 Nov 2025 00:00:00 -0500_  
  arXiv:2411.06635v4 Announce Type: replace-cross 
Abstract: Single-cell RNA sequencing enables high-resolution analysis of cellular heterogeneity, yet disentangling biological signal from batch effects remains a major challenge. Existing batch-correction algorithms suppress or discard batch-related variation rather tha…
